Macular Degeneration News and Research RSS Feed - Macular Degeneration News and Research

Macular degeneration is a disease associated with aging that gradually destroys sharp, central vision. Central vision is needed for seeing objects clearly and for common daily tasks such as reading and driving.
Six NIH-funded projects aim to identify biological factors that affect neural regeneration

Six NIH-funded projects aim to identify biological factors that affect neural regeneration

The National Institutes of Health will fund six projects to identify biological factors that affect neural regeneration in the retina. [More]
Gentle combination of FDA-approved drugs could combat photoreceptor degeneration in mice

Gentle combination of FDA-approved drugs could combat photoreceptor degeneration in mice

In microseconds, every light ray that enters the eye triggers an explosion of coordinated cellular events. [More]
RPB continues research initiative to address urgent needs in treating low vision

RPB continues research initiative to address urgent needs in treating low vision

Research to Prevent Blindness is continuing its research initiative to address urgent needs in understanding and treating low vision. [More]
Research opens way towards making promising advances in retinal prostheses

Research opens way towards making promising advances in retinal prostheses

A major therapeutic challenge, the retinal prostheses that have been under development during the past ten years can enable some blind subjects to perceive light signals, but the image thus restored is still far from being clear. [More]
Combinations of FDA-approved drugs may prevent vision loss linked to retinal degeneration

Combinations of FDA-approved drugs may prevent vision loss linked to retinal degeneration

Combinations of Food and Drug Administration-approved drugs protect against the loss of cells required for vision in a mouse model of blinding retinal diseases. [More]
Researchers find potential way for delivering gene therapy to treat eye diseases

Researchers find potential way for delivering gene therapy to treat eye diseases

Eye diseases such as diabetic retinopathy and age-related macular degeneration are among the leading causes of irreversible vision loss and blindness worldwide. Currently, gene therapy can be administered to treat these conditions -- but this requires an injection. [More]
Clinical trial to assess safety of using umbilical cord cells to treat macular degeneration

Clinical trial to assess safety of using umbilical cord cells to treat macular degeneration

UIC is part of a national phase 2 clinical trial to evaluate the safety and tolerability of using cells derived from multipotent umbilical cord cells to treat age-related macular degeneration, the most common cause of vision loss in people over 55. [More]
Study pinpoints how immune abnormalities in retina may lead to macular degeneration

Study pinpoints how immune abnormalities in retina may lead to macular degeneration

In a study published this week in the Proceedings of the National Academy of Sciences, a University of Wisconsin-Madison research team pinpoints how immune abnormalities beneath the retina result in macular degeneration, a common condition that often causes blindness. [More]
Nanoscope researchers develop novel VMCO and NOD platform for patients with vision loss

Nanoscope researchers develop novel VMCO and NOD platform for patients with vision loss

According to the World Health Organization, approximately 285 million people are estimated to be visually impaired worldwide. Age-related macular degeneration (AMD) is a major cause of vision loss in aging populations. [More]
Buck researchers find new way for possible treatment of AMD

Buck researchers find new way for possible treatment of AMD

Buck researchers boosted the potency of a broccoli-related compound by ten times and identified it as a possible treatment for age-related macular degeneration (AMD), the leading cause of vision loss affecting more than 10 million older Americans. [More]
Diabetes drug metformin could help reduce toxic acid levels linked to MSUD

Diabetes drug metformin could help reduce toxic acid levels linked to MSUD

Maple Syrup Urine Disease (MSUD) is a rare inherited metabolic disorder involving the dysfunction of an enzyme which breaks down three essential amino acids: leucine, isoleucine and valine. [More]
Routine eye examinations lead to change in vision prescription or care in asymptomatic patients

Routine eye examinations lead to change in vision prescription or care in asymptomatic patients

Do you really need to get your eyes checked—even if you haven't noticed any vision problems or eye-related symptoms? More than half of routine eye examinations in asymptomatic patients lead to a change in vision prescription or other changes in care, according to a study in the June issue of Optometry and Vision Science, official journal of the American Academy of Optometry. [More]
New research could pave way for improving retinal implants

New research could pave way for improving retinal implants

Engineers and neuroscientists at the University of Sheffield have demonstrated for the first time that the cells in the retina carry out key processing tasks. This could pave the way for improving retinal implants and therefore the sight of thousands of people suffering from retinal disorders. [More]
Pain reliever appears to help preserve vision in animal model of retinal degeneration

Pain reliever appears to help preserve vision in animal model of retinal degeneration

A pain medicine that potently activates a receptor vital to a healthy retina appears to help preserve vision in a model of severe retinal degeneration, scientists report. [More]
Eye donations: what stops people? An interview with Rory Passmore

Eye donations: what stops people? An interview with Rory Passmore

Despite a shortage of corneas for transplant purposes, our new research reveals that eyes are the one body part we are least likely to donate. [More]
Complex 36-point therapeutic personalized program can help reverse memory loss in early AD patients

Complex 36-point therapeutic personalized program can help reverse memory loss in early AD patients

Results from quantitative MRI and neuropsychological testing show unprecedented improvements in ten patients with early Alzheimer's disease (AD) or its precursors following treatment with a programmatic and personalized therapy. Results from an approach dubbed metabolic enhancement for neurodegeneration are now available online in the journal Aging. [More]
Buck researchers identify new, potential drug targets for sporadic PD

Buck researchers identify new, potential drug targets for sporadic PD

Research at the Buck Institute shows the same mechanisms that lead to neuronal cell death in mice genetically fated to develop Parkinson's disease (PD) are involved in the much more common sporadic form of the age-related, neurodegenerative disorder that robs people of the ability to move normally. [More]
Small drug-like molecule that alters perception of food may hold key to extending human healthspan

Small drug-like molecule that alters perception of food may hold key to extending human healthspan

Researchers at the Buck Institute have shown a new effect on aging via a small drug-like molecule that alters the perception of food in the nematode C. elegans. Publishing in Aging Cell, researchers "tricked" the worm's metabolism into a state of caloric restriction, extending the animal's lifespan by 50 percent. [More]
Vision Express advises Britons to be 'sun safe' when choosing eyewear

Vision Express advises Britons to be 'sun safe' when choosing eyewear

Britons are putting their sight at risk – potentially exposing themselves to cataracts and macular degeneration – by choosing vanity over UV protection when buying sunglasses, new research from Vision Express has revealed. [More]
NIH-funded study finds visual impairment, blindness may double by 2050

NIH-funded study finds visual impairment, blindness may double by 2050

With the youngest of the baby boomers hitting 65 by 2029, the number of people with visual impairment or blindness in the United States is expected to double to more than 8 million by 2050, according to projections based on the most recent census data and from studies funded by the National Eye Institute, part of the National Institutes of Health. [More]
Advertisement
Advertisement